Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Danicamtiv Enhances Systolic F...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Danicamtiv Enhances Systolic Function and Frank‐Starling Behavior at Minimal Diastolic Cost in Engineered Human Myocardium

Danicamtiv Enhances Systolic Function and Frank‐Starling Behavior at Minimal Diastolic Cost in Engineered Human Myocardium

Bibliographic Details
Main Authors: Shi Shen, Lorenzo R. Sewanan, Daniel L. Jacoby, Stuart G. Campbell
Format: Article
Language:English
Published: Wiley 2021-06-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
danicamtiv
engineered heart tissues
inotropes
myotropes
omecamtiv mecarbil
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.121.020860
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.121.020860

Similar Items

  • Omecamtiv Mecarbil in the treatment of heart failure: the past, the present, and the future
    by: Shujing Zhou, et al.
    Published: (2024-03-01)
  • Cardiac myosin activation in the treatment of congestive heart failure: New therapeutic options and review of literature
    by: Arroj Ali, et al.
    Published: (2021-01-01)
  • Cardiac myosin activators for heart failure therapy: focus on omecamtiv mecarbil
    by: Edgardo Kaplinsky, et al.
    Published: (2018-04-01)
  • Omecamtiv mecarbil in precision-cut living heart failure slices: A story of a double-edged sword
    by: Jorik H. Amesz, et al.
    Published: (2023-09-01)
  • The myosin activator omecamtiv mecarbil improves wall stress in a rat model of chronic aortic regurgitation
    by: Bachar El Oumeiri, et al.
    Published: (2021-08-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs